Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 23593016)

1.

Iron-responsive miR-485-3p regulates cellular iron homeostasis by targeting ferroportin.

Sangokoya C, Doss JF, Chi JT.

PLoS Genet. 2013 Apr;9(4):e1003408. doi: 10.1371/journal.pgen.1003408. Epub 2013 Apr 4.

2.

Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice.

Taylor M, Qu A, Anderson ER, Matsubara T, Martin A, Gonzalez FJ, Shah YM.

Gastroenterology. 2011 Jun;140(7):2044-55. doi: 10.1053/j.gastro.2011.03.007. Epub 2011 Mar 17.

3.

In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations.

Schimanski LM, Drakesmith H, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, Bastin JM, Cowley D, Chinthammitr Y, Robson KJ, Townsend AR.

Blood. 2005 May 15;105(10):4096-102. Epub 2005 Feb 3.

4.

Effect of ferroportin polymorphism on iron homeostasis and infection.

Kasvosve I.

Clin Chim Acta. 2013 Feb 1;416:20-5. doi: 10.1016/j.cca.2012.11.013. Epub 2012 Nov 21. Review.

PMID:
23178444
5.

The role of ubiquitination in hepcidin-independent and hepcidin-dependent degradation of ferroportin.

De Domenico I, Lo E, Yang B, Korolnek T, Hamza I, Ward DM, Kaplan J.

Cell Metab. 2011 Nov 2;14(5):635-46. doi: 10.1016/j.cmet.2011.09.008. Epub 2011 Oct 20. Retraction in: Cell Metab. 2012 Jun 6;15(6):927.

6.

Human mutation D157G in ferroportin leads to hepcidin-independent binding of Jak2 and ferroportin down-regulation.

De Domenico I, Lo E, Ward DM, Kaplan J.

Blood. 2010 Apr 8;115(14):2956-9. doi: 10.1182/blood-2009-10-251306. Epub 2010 Feb 2.

7.

Ferroportin-1 is a 'nuclear'-negative acute-phase protein in rat liver: a comparison with other iron-transport proteins.

Naz N, Malik IA, Sheikh N, Ahmad S, Khan S, Blaschke M, Schultze F, Ramadori G.

Lab Invest. 2012 Jun;92(6):842-56. doi: 10.1038/labinvest.2012.52.

8.

Cell-specific regulation of Ferroportin transcription following experimentally-induced acute anemia in mice.

Chiabrando D, Fiorito V, Marro S, Silengo L, Altruda F, Tolosano E.

Blood Cells Mol Dis. 2013 Jan;50(1):25-30. doi: 10.1016/j.bcmd.2012.08.002. Epub 2012 Aug 24.

PMID:
22921471
9.

Ferroportin-mediated iron transport: expression and regulation.

Ward DM, Kaplan J.

Biochim Biophys Acta. 2012 Sep;1823(9):1426-33. doi: 10.1016/j.bbamcr.2012.03.004. Epub 2012 Mar 13. Review.

10.

Ferroportin diseases: functional studies, a link between genetic and clinical phenotype.

Détivaud L, Island ML, Jouanolle AM, Ropert M, Bardou-Jacquet E, Le Lan C, Mosser A, Leroyer P, Deugnier Y, David V, Brissot P, Loréal O.

Hum Mutat. 2013 Nov;34(11):1529-36. doi: 10.1002/humu.22396. Epub 2013 Sep 11.

PMID:
23943237
11.

The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.

Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC.

Cell Metab. 2005 Mar;1(3):191-200.

12.

Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload.

Altamura S, Kessler R, Gröne HJ, Gretz N, Hentze MW, Galy B, Muckenthaler MU.

Cell Metab. 2014 Aug 5;20(2):359-67. doi: 10.1016/j.cmet.2014.07.007.

13.

Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.

Drakesmith H, Schimanski LM, Ormerod E, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, Bastin JM, Cowley D, Chinthammitr Y, Robson KJ, Townsend AR.

Blood. 2005 Aug 1;106(3):1092-7. Epub 2005 Apr 14.

14.

The molecular basis of hepcidin-resistant hereditary hemochromatosis.

Fernandes A, Preza GC, Phung Y, De Domenico I, Kaplan J, Ganz T, Nemeth E.

Blood. 2009 Jul 9;114(2):437-43. doi: 10.1182/blood-2008-03-146134. Epub 2009 Apr 21.

15.

The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease.

Zohn IE, De Domenico I, Pollock A, Ward DM, Goodman JF, Liang X, Sanchez AJ, Niswander L, Kaplan J.

Blood. 2007 May 15;109(10):4174-80. Epub 2007 Feb 8.

16.

Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function.

Lakhal-Littleton S, Wolna M, Carr CA, Miller JJ, Christian HC, Ball V, Santos A, Diaz R, Biggs D, Stillion R, Holdship P, Larner F, Tyler DJ, Clarke K, Davies B, Robbins PA.

Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):3164-9. doi: 10.1073/pnas.1422373112. Epub 2015 Feb 23. Erratum in: Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):E1812.

17.

Inhibition of c-FLIP expression by miR-512-3p contributes to taxol-induced apoptosis in hepatocellular carcinoma cells.

Chen F, Zhu HH, Zhou LF, Wu SS, Wang J, Chen Z.

Oncol Rep. 2010 May;23(5):1457-62.

PMID:
20372864
18.

The iron-regulatory hormone hepcidin: a possible therapeutic target?

Rochette L, Gudjoncik A, Guenancia C, Zeller M, Cottin Y, Vergely C.

Pharmacol Ther. 2015 Feb;146:35-52. doi: 10.1016/j.pharmthera.2014.09.004. Epub 2014 Sep 7.

PMID:
25205158
19.

Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT.

Ross SL, Tran L, Winters A, Lee KJ, Plewa C, Foltz I, King C, Miranda LP, Allen J, Beckman H, Cooke KS, Moody G, Sasu BJ, Nemeth E, Ganz T, Molineux G, Arvedson TL.

Cell Metab. 2012 Jun 6;15(6):905-17. doi: 10.1016/j.cmet.2012.03.017.

20.

Quercetin inhibits intestinal iron absorption and ferroportin transporter expression in vivo and in vitro.

Lesjak M, Hoque R, Balesaria S, Skinner V, Debnam ES, Srai SK, Sharp PA.

PLoS One. 2014 Jul 24;9(7):e102900. doi: 10.1371/journal.pone.0102900. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk